Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

35.51
Delayed Data
As of Apr 27
 -0.62 / -1.72%
Today’s Change
9.40
Today|||52-Week Range
48.21
+183.63%
Year-to-Date
No recent news for Esperion Therapeutics Inc.

Today’s Trading

Previous close36.13
Today’s open36.05
Day’s range35.36 - 36.69
Volume492,375
Average volume (3 months)1,591,037
Market cap$801.0M
Dividend yield--
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)-47.35%
Earnings growth (this year)--
Earnings growth (next 5 years)-5.76%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.50

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...+0.17+1.52%
HRTXHeron Therapeutics I...+0.10+0.66%
MGNXMacroGenics Inc+0.07+0.32%
DEPODepomed Inc-0.18-1.46%
Data as of 04/27/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$1.45
Annual revenue (last year)$0.00
Annual profit (last year)-$75.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tim M. Mayleben
COO, Executive VP-Research &
Development
Narendra D. Lalwani
Corporate headquarters
Ann Arbor, Michigan

Forecasts